Upstream Bio Inc. (UPB) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Upstream Bio Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$2.98
+6.81% today
Market cap
$153M
Overall quality
—
Kronos AI 30-day
+125.6%
8 of 8 simulated paths end higher
Upstream Bio Inc. (UPB) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $153M. It trades at $2.98, up 6.81% today. 5 analysts' average target of $22.25 implies +646.6% from today's price. Kronos AI's 30-day forecast is +125.6% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $22.25 |
| Low – high | $9.00 – $36.00 |
| Analysts | 5 |
| Upside to average | +646.6% |
Kronos AI 30-day forecast
| Expected close | $6.30 (+125.6%) |
| Likely range | +107.3% … +137.0% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.